Defective cholesterol metabolism in amyotrophic lateral sclerosis patient-oriented and epidemiological
暂无分享,去创建一个
M. Turner | K. Talbot | W. Griffiths | Yuqin Wang | E. Gray | P. Crick | E. Yutuc | M. Warner | Jonas Abdel-Khalik | Gustavo Román | J. Gustafsson | Eylan Yutuc | M. Turner
[1] P. Clayton,et al. Sterols and oxysterols in plasma from Smith-Lemli-Opitz syndrome patients , 2017, The Journal of Steroid Biochemistry and Molecular Biology.
[2] N. Grishin,et al. Direct Demonstration That Loop1 of Scap Binds to Loop7 , 2016, The Journal of Biological Chemistry.
[3] Eoin Fahy,et al. Metabolomics Workbench: An international repository for metabolomics data and metadata, metabolite standards, protocols, tutorials and training, and analysis tools , 2015, Nucleic Acids Res..
[4] J. Gustafsson. Control of gene expression by novel metabolic intermediates , 2015, The Journal of Steroid Biochemistry and Molecular Biology.
[5] W. Griffiths,et al. Cholesterol metabolites exported from human brain , 2015, Steroids.
[6] M. Turner,et al. The longitudinal cerebrospinal fluid metabolomic profile of amyotrophic lateral sclerosis , 2015, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[7] P. Clayton,et al. Quantitative charge-tags for sterol and oxysterol analysis. , 2015, Clinical chemistry.
[8] P. Andersen,et al. Cholesterol, Oxysterol, Triglyceride, and Coenzyme Q Homeostasis in ALS. Evidence against the Hypothesis That Elevated 27-Hydroxycholesterol Is a Pathogenic Factor , 2014, PloS one.
[9] R. Schüle,et al. Cholestenoic acids regulate motor neuron survival via liver X receptors. , 2014, The Journal of clinical investigation.
[10] D. Russell,et al. 25-Hydroxycholesterol suppresses interleukin-1–driven inflammation downstream of type I interferon , 2014, Science.
[11] C. Betsholtz,et al. Effects of a Disrupted Blood-Brain Barrier on Cholesterol Homeostasis in the Brain* , 2014, The Journal of Biological Chemistry.
[12] R. Evans,et al. Nuclear Receptors, RXR, and the Big Bang , 2014, Cell.
[13] Patrick Emond,et al. Metabolomics in cerebrospinal fluid of patients with amyotrophic lateral sclerosis: an untargeted approach via high-resolution mass spectrometry. , 2013, Journal of proteome research.
[14] William J Griffiths,et al. Analytical strategies for characterization of oxysterol lipidomes: liver X receptor ligands in plasma. , 2013, Free radical biology & medicine.
[15] Albert Ludolph,et al. Mechanisms, models and biomarkers in amyotrophic lateral sclerosis , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[16] H. Shang,et al. Statins and amyotrophic lateral sclerosis: a systematic review and meta-analysis , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[17] I. Björkhem. Five decades with oxysterols. , 2013, Biochimie.
[18] M. Turner,et al. Inflammation and neurovascular changes in amyotrophic lateral sclerosis , 2013, Molecular and Cellular Neuroscience.
[19] N. Javitt,et al. 27-Hydroxycholesterol, does it exist? On the nomenclature and stereochemistry of 26-hydroxylated sterols , 2012, Steroids.
[20] Ewout J. N. Groen,et al. Mapping of Gene Expression Reveals CYP27A1 as a Susceptibility Gene for Sporadic ALS , 2012, PloS one.
[21] F. Pfrieger,et al. Cholesterol metabolism in neurons and astrocytes. , 2011, Progress in lipid research.
[22] L. Karlsson,et al. Oxysterols direct B-cell migration through EBI2 , 2011, Nature.
[23] P. Schultz,et al. Oxysterols direct immune cell migration via EBI2 , 2011, Nature.
[24] L. H. van den Berg,et al. Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis , 2011, Journal of Neurology, Neurosurgery & Psychiatry.
[25] P. Andersen,et al. Disease-Related Changes in the Cerebrospinal Fluid Metabolome in Amyotrophic Lateral Sclerosis Detected by GC/TOFMS , 2011, PloS one.
[26] J. Kassubek,et al. Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis , 2011, Journal of Neurology.
[27] Patrick Emond,et al. 1H-NMR-Based Metabolomic Profiling of CSF in Early Amyotrophic Lateral Sclerosis , 2010, PloS one.
[28] J. Gustafsson,et al. Neuropathologic and Biochemical Changes During Disease Progression in Liver X Receptor &bgr;−/− Mice, A Model of Adult Neuron Disease , 2010, Journal of neuropathology and experimental neurology.
[29] Alok Kumar,et al. Metabolomic analysis of serum by (1) H NMR spectroscopy in amyotrophic lateral sclerosis. , 2010, Clinica chimica acta; international journal of clinical chemistry.
[30] Andrew Lockhart,et al. Cerebrospinal Fluid Steroidomics: Are Bioactive Bile Acids Present in Brain?* , 2009, The Journal of Biological Chemistry.
[31] S. Ferdinandusse,et al. Bile acids: the role of peroxisomes , 2009, Journal of Lipid Research.
[32] D. Russell,et al. Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain. , 2009, Annual review of biochemistry.
[33] V. Meininger,et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis , 2008, Neurology.
[34] Joseph L. Goldstein,et al. Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: Oxysterols block transport by binding to Insig , 2007, Proceedings of the National Academy of Sciences.
[35] I. Björkhem. Rediscovery of Cerebrosterol , 2007, Lipids.
[36] P. Clayton,et al. Disorders of bile acid synthesis , 2006, Journal of Inherited Metabolic Disease.
[37] P. Tontonoz,et al. Liver X receptors as integrators of metabolic and inflammatory signaling. , 2006, The Journal of clinical investigation.
[38] Steve Meaney,et al. Crossing the barrier: Published, JLR Papers in Press, March 1, 2005. DOI 10.1194/jlr.M500024-JLR200 net flux of 27-hydroxycholesterol into the human brain , 2005, Journal of Lipid Research.
[39] C. Glass,et al. A comprehensive classification system for lipids. , 2005, Journal of lipid research.
[40] J. Gustafsson,et al. Inactivation of liver X receptor beta leads to adult-onset motor neuron degeneration in male mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[41] M. Eriksson,et al. Patients with atherosclerosis may have increased circulating levels of 27‐hydroxycholesterol and cholestenoic acid , 2005, Scandinavian journal of clinical and laboratory investigation.
[42] J. Dietschy,et al. Thematic review series: Brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal Published, JLR Papers in Press, May 16, 2004. DOI 10.1194/jlr.R400004-JLR200 , 2004, Journal of Lipid Research.
[43] L. Wahlund,et al. Diagnostic use of cerebral and extracerebral oxysterols , 2004, Clinical chemistry and laboratory medicine.
[44] D. Russell. The enzymes, regulation, and genetics of bile acid synthesis. , 2003, Annual review of biochemistry.
[45] F. Violi,et al. Measurement of oxysterols and alpha-tocopherol in plasma and tissue samples as indices of oxidant stress status. , 2003, Analytical biochemistry.
[46] M. Mattson,et al. Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress–induced death of motor neurons in amyotrophic lateral sclerosis , 2002, Annals of neurology.
[47] L. Wahlund,et al. Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases , 2000, Neuroscience Letters.
[48] E. Baulieu,et al. Metabolism of 27-, 25- and 24-hydroxycholesterol in rat glial cells and neurons. , 1997, The Biochemical journal.
[49] U. Diczfalusy,et al. Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry. , 1995, Analytical biochemistry.
[50] A. Ludolph,et al. Amyotrophic lateral sclerosis. , 2012, Current opinion in neurology.
[51] W. Griffiths,et al. The effect of 24S-hydroxycholesterol on cholesterol homeostasis in neurons: quantitative changes to the cortical neuron proteome. , 2008, Journal of proteome research.